Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival

Introduction Concurrent chemoradiation is the standard of care in inoperable locally advanced squamous cell head and neck cancers. The most widely accepted schedule of concomitant cisplatin is 100mg/m(2) given on a 3 weekly basis but the optimal regime is unknown. Objective The objective of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Muhammad Shahid, Chaw, Cheng, Kovarik, Josef, Aslam, Shahzeena, Jackson, Aaron, Kelly, John, Dobrowsky, Werner, Kelly, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme-Revinter Publicações Ltda 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375948/
https://www.ncbi.nlm.nih.gov/pubmed/28382126
http://dx.doi.org/10.1055/s-0036-1594020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5375948/
https://www.ncbi.nlm.nih.gov/pubmed/28382126
http://dx.doi.org/10.1055/s-0036-1594020

Ejemplares similares